Stock LPCN LIPOCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Lipocine Inc.

Equities

LPCN

US53630X2036

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
7.52 USD +6.21% Intraday chart for Lipocine Inc. +8.67% +169.53%
May. 09 Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M MT
May. 09 Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024
PR
Lipocine: Q1 Earnings Snapshot
AQ
Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024
PR
Lipocine : Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024 - Form 8-K
PU
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154
PR
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
AQ
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
PR
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
PR
Lipocine : Announces First Cohort Dosed in Pivotal Study of LPCN 1154 - Form 8-K
PU
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
AQ
Lipocine : Announces Financial Results for the Full Year Ended December 31, 2023 - Form 8-K
PU
Lipocine to Present at 36th Annual Roth Conference
PR
Lipocine : to Present at 36th Annual Roth Conference - Form 8-K
PU
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154
PR
Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals
PR
Lipocine and Verity Pharma Enter into License Agreement for TLANDO Franchise in the U.S. and Canada
AQ
Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada
PR
Lipocine to Present at Biotech Showcase 2024
PR
Lipocine: Q3 Earnings Snapshot
AQ
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LPCN Stock
  4. News Lipocine Inc.
  5. Press Releases